CIRCULATING MIRNAS AS DIAGNOSTIC BIOMARKERS FOR PERIODONTITIS

Benita Buragaite-Staponkiene1, Kristina Snipaitiene1, Adomas Rovas2, Ruta Matuleviciute1, Egle Punceviciene3, Irena Butrimiene3, Alina Puriene1, 2, Sonata Jarmalaite1

1 Human Genome Research Group, Life Sciences Center, Vilnius University, Vilnius, Lithuania

2 Vilnius University Hospital Zalgiris Clinic, Vilnius, Lithuania

3 Vilnius University Hospital Santaros Clinics, Vilnius, Lithuania

[email protected]

Periodontitis (PD) is highly prevalent inflammatory oral disease affecting the supporting tissues of the teeth and leading to connective tissue attachment loss and bone resorption. Besides its negative impact on quality of life, PD is also strongly associated with an increased risk of particular systemic disorders, e.g., respiratory and cardiovascular diseases, rheumatoid arthritis, diabetes, cancer etc. [1-5]. Various mechanisms of PD pathogenesis are epigenetically regulated and microRNAs (miRNAs) are considered as one of the key modulators that influences periodontal homeostasis. This study aimed to reveal PD-associated miRNAs in gingival tissue and bodily fluids, including gingival crevicular fluid (GCF), saliva and plasma, and to evaluate the utility of those miRNAs as minimally- and non-invasive diagnostic markers for PD.

MiRNA expression was profiled in eight gingival tissue samples using microarray platform (Human miRNA Microarrays, 8x60K format). Four significantly differently expressed miRNAs were validated in gingival tissue samples (N=61) and further analyzed in bodily fluid specimens (N=171) by means of quantitative reverse transcription PCR.

A number of miRNAs was found to be significantly upregulated in inflamed gingival tissues as compared to periodontally healthy tissues. After thorough validation, miR-199a-5p, miR-483-5p, miR-3198 and miR-4299 were analyzed in bodily fluids. The level of GCF miR-3198 was significantly higher amongst participants with PD (P=0.019). The level of miR-199a-5p was increased in saliva samples from patients with severe PD (P=0.045), and decreased in plasma samples collected from PD-affected patients (P=0.008), as compared to periodontally healthy participants (P<0.050). A combination of GCF miR-3198 and miR-4299 demonstrated high diagnostic potential (AUC=0.86, P<0.0001) with 68% sensitivity and 96% specificity (Fig. 1).

Figure 1
Fig. 1. ROC curve analysis of gingival crevicular fluid (GCF) -derived miR-3198, miR-4299 and a combination of them.

The results of the current study suggest that PD-specific inflammatory miRNAs in bodily fluids can serve as potential biomarkers of PD that could be applied for minimally- and non-invasive diagnostics of the disease.


[1] X.T. Zeng, M.L. Tu, D.Y. Liu, et al., Periodontal disease and risk of chronic obstructive pulmonary disease: A meta-analysis of observational studies, PLoS One 7(10), e46508 (2012).

[2] A. Blaizot, J.N. Vergnes, S. Nuwwareh et al., Periodontal diseases and cardiovascular events: meta-analysis of observational studies, Int Dent J. 59, 197-209 (2009).

[3] X. Zhao, Z. Liu, D. Shu et al., Association of Periodontitis with Rheumatoid Arthritis and the Effect of Non-Surgical Periodontal Treatment on Disease Activity in Patients with Rheumatoid Arthritis. Med Sci Monit. 24, 5802-5810 (2018).

[4] M.H. Patel, J.V. Kumar, M.E. Moss, Diabetes and tooth loss: An analysis of data from the national health and nutrition examination survey, 2003-2004. J Am Dent Assoc. 144, 478-485 (2013).

[5] D.C. Güven, Ö. Dizdar, A.C. Akman et al., Evaluation of cancer risk in patients with periodontal diseases. Turk J Med Sci. 49(3), 826-831 (2019).